Peters Malte
Transaction: 08/19/2025
SELL
Change
-25,172
Price
$0.82
Filing
10/09/2025
Type
SELL
HOOKIPA Pharma Inc.
HOOK • Biotechnology
$1.15
— 0.00 (0.00%)
Current price
EarningsLatest report: Dec 31, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$14.59M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 6.35Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.15
Change0.00%
Shares Out12.68M
Market Cap$14.59M
Enterprise Value$-19.64M
52W Range0.81 - 1.55
Beta0.77
P/E-0.26
P/S0.98
P/B0.51
P/FCF-0.32
EV/Sales-1.32
Price$1.15
Change0.00%
Shares Out12.68M
Market Cap$14.59M
Enterprise Value$-19.64M
52W Range0.81 - 1.55
Beta0.77
P/E-0.26
P/S0.98
P/B0.51
P/FCF-0.32
EV/Sales-1.32
EV/EBITDA0.36
EV/FCF0.43
Earnings Yield-383.98%
FCF Yield-312.51%
Dividend Yield0.00%
Gross Margin92.97%
Oper. Margin-3.77%
Profit Margin-142.63%
Debt/Eq0.00
Current Ratio6.35
Quick Ratio6.35
Target$3.00
Target Upside160.87%
Target Median$3.00
Target Range3.00 - 3.00
Volume0.00
Avg Volume11.96K
EPS Surprise0.70
Investment DNA
How strong this company looks for long-term investors
42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 6.35Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
72/100
Bullish
Bullish
5
Hold
3
Bearish
1
Price Target
2026-08-09
Low
$3.00
Mean
$3.00
Median
$3.00
High
$3.00
Insider Transactions
Recent executive and insider activity
Coelho Mary Theresa
Transaction: 07/22/2025
SELL
Change
-13,609
Price
$0.92
Filing
07/23/2025
Type
SELL
Peters Malte
Transaction: 07/22/2025
SELL
Change
-29,176
Price
$0.92
Filing
07/23/2025
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Peters Malte | SELL | -25,172 | $0.82 | 08/19/2025 | 10/09/2025 |
| Coelho Mary Theresa | SELL | -13,609 | $0.92 | 07/22/2025 | 07/23/2025 |
| Peters Malte | SELL | -29,176 | $0.92 | 07/22/2025 | 07/23/2025 |
| Cassidy Sean A | OTHER | 0 | Not reported | 07/22/2024 | 07/24/2024 |
| Cassidy Sean A | BUY | +9,800 | $6.44 | 07/22/2024 | 07/24/2024 |
| Peters Malte | BUY | +108,695 | Not reported | 07/22/2024 | 07/24/2024 |
| Coelho Mary Theresa | BUY | +69,875 | Not reported | 07/22/2024 | 07/24/2024 |
| Reilly Timothy P. | BUY | +49,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| Coelho Mary Theresa | BUY | +49,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| O'Neill Julie | BUY | +49,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| Kaufman David Ross | BUY | +49,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| van de Winkel Jan | BUY | +98,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| Peters Malte | BUY | +49,000 | $0.71 | 06/17/2024 | 06/18/2024 |
| Necina Roman | BUY | +367,300 | $0.76 | 04/15/2024 | 04/17/2024 |
| Kandera Reinhard | BUY | +406,200 | $0.76 | 04/15/2024 | 04/17/2024 |
| Winderlich Mark | BUY | +50,000 | $0.76 | 04/15/2024 | 04/17/2024 |
| Aldag Jorn | BUY | +971,400 | $0.76 | 04/15/2024 | 04/17/2024 |
| Orlinger Klaus | BUY | +367,300 | $0.76 | 04/15/2024 | 04/17/2024 |
| Winderlich Mark | OTHER | 0 | Not reported | 04/01/2024 | 04/11/2024 |
| GILEAD SCIENCES, INC. | SELL | 0 | Not reported | 12/20/2023 | 12/22/2023 |